Tags

Type your tag names separated by a space and hit enter

Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Pathol Oncol Res. 2020 10; 26(4):2823-2825.PO

Links

PMC Free PDF

Authors+Show Affiliations

Tsiambas E
Department of Cytology, 401 & 417 VA Hospital (NIMTS), Athens, Greece. tsiambasecyto@yahoo.gr. Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece. tsiambasecyto@yahoo.gr.
Papanikolaou V
1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.
Chrysovergis A
1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.
Mastronikolis N
Department of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Patras, Greece.
Ragos V
Department of Maxillofacial Surgery, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Kavantzas N
Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece.
Lazaris AC
Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece.
Kyrodimos E
1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.

MeSH

Angiotensin-Converting Enzyme 2BetacoronavirusBiomarkersCOVID-19Coronavirus InfectionsHematologic NeoplasmsHumansImmunocompromised HostPandemicsPeptidyl-Dipeptidase APneumonia, ViralPolymorphism, Single NucleotideSARS-CoV-2

Pub Type(s)

Letter

Language

eng

PubMed ID

32333199

Citation

Tsiambas, Evangelos, et al. "Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19." Pathology Oncology Research : POR, vol. 26, no. 4, 2020, pp. 2823-2825.
Tsiambas E, Papanikolaou V, Chrysovergis A, et al. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. Pathol Oncol Res. 2020;26(4):2823-2825.
Tsiambas, E., Papanikolaou, V., Chrysovergis, A., Mastronikolis, N., Ragos, V., Kavantzas, N., Lazaris, A. C., & Kyrodimos, E. (2020). Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. Pathology Oncology Research : POR, 26(4), 2823-2825. https://doi.org/10.1007/s12253-020-00810-6
Tsiambas E, et al. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. Pathol Oncol Res. 2020;26(4):2823-2825. PubMed PMID: 32333199.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. AU - Tsiambas,Evangelos, AU - Papanikolaou,Vasileios, AU - Chrysovergis,Aristeidis, AU - Mastronikolis,Nicholas, AU - Ragos,Vasileios, AU - Kavantzas,Nikolaos, AU - Lazaris,Andreas C, AU - Kyrodimos,Efthymios, Y1 - 2020/04/24/ PY - 2020/03/16/received PY - 2020/03/26/accepted PY - 2020/4/26/pubmed PY - 2020/9/17/medline PY - 2020/4/26/entrez SP - 2823 EP - 2825 JF - Pathology oncology research : POR JO - Pathol Oncol Res VL - 26 IS - 4 SN - 1532-2807 UR - https://www.unboundmedicine.com/medline/citation/32333199/Coronavirus_in_Hematologic_Malignancies:_Targeting_Molecules_Beyond_the_Angiotensin_Converting_Enzyme_2__ACE2__Wall_in_COVID_19_ DB - PRIME DP - Unbound Medicine ER -